Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission
- Sponsor
- Asmaa mohammed abdelaal abdelaal
- Study ID
- NCT06691451
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Inflammatory Bowel Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Study Details
Inherited thombopllia and thrombotic risks in inflammatory bowel Disease during activity and remission
Key Dates
- First listed
- Nov 15, 2024
- Start date
- Nov 30, 2024
- Status verified
- Nov 2024
- Primary completion
- Dec 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 93 participants (estimated)
Primary Outcome Measure
Comparison between the number of IBD patients with tendency to thrombosis in cases of activity- [ Time Frame: Baseline ]
Central Contacts
- Asmaa Mohammed Abdelaal, Master01066239562
Related Studies
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic TestingRecruiting · University of Chicago · Chicago, Illinois
- Improving the Quality of Care for Adults With Inflammatory Bowel DiseaseEnrolling By Invitation · Dartmouth-Hitchcock Medical Center · Los Angeles, California
- CorEvitas Inflammatory Bowel Disease (IBD) RegistryEnrolling By Invitation · CorEvitas · Waltham, Massachusetts
- Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)Enrolling By Invitation · Boston Children's Hospital · Boston, Massachusetts